Geode Capital Management
BIAF icon

Geode Capital Management’s bioAffinity Technologies BIAF Stock Holding History

Geode Capital Management’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,398
Closed -$41.4K – 4401
2026
Q2 		$41.4K Buy
3,398
+178
+6% +$5.45K ﹤0.01% 4282
2026
Q1 		$185K Buy
3,220
+1,192
+59% +$28.9K ﹤0.01% 3936
2025
Q4 		$35.9K Buy
+2,028
New +$60.6K ﹤0.01% 4290
2025
Q3 		– Sell
-279
Closed -$36K – 4486
2025
Q2 		$36K Buy
279
+15
+6% +$2.57K ﹤0.01% 4276
2025
Q1 		$30.9K Buy
264
+43
+19% +$11.8K ﹤0.01% 4280
2024
Q4 		$93K Buy
221
+27
+14% +$16.3K ﹤0.01% 4114
2024
Q3 		$181K Buy
194
+39
+25% +$35.1K ﹤0.01% 3935
2024
Q2 		$150K Buy
155
+61
+65% +$63.4K ﹤0.01% 4009
2024
Q1 		$85K Buy
94
+12
+15% +$9.39K ﹤0.01% 4209
2023
Q4 		$54.8K Buy
+82
New +$52.6K ﹤0.01% 4325

Other funds holding BIAF

Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Geode Capital Management's BIAF Position: Q3 2026 in Review

Geode Capital Management sold out of bioAffinity Technologies (BIAF) in Q3 2026, closing a stake of 3,398 shares — an estimated $41.4K sold.

Geode Capital Management first reported a position in BIAF in Q4 2023 and held it in 10 quarters. The position peaked at $185K in Q1 2026. 5 funds tracked by Wall St. Rank hold BIAF as of Q3 2026.

  • Geode Capital Management reported no remaining bioAffinity Technologies position as of Q3 2026 after selling out during the quarter.
  • Geode Capital Management sold 3,398 bioAffinity Technologies shares in Q3 2026, an estimated $41.4K.
  • Geode Capital Management first reported a position in bioAffinity Technologies in Q4 2023 and held it in 10 quarters.
  • Geode Capital Management's bioAffinity Technologies position peaked at $185K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.